JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF ...
WHOWHATWHEREWHENWHYNuwellis, Inc., and Dr. Sean P. Pinney and Dr. Maria V. DeVitaUpdated analysis of the AVOID-HF study data shows that Aquadex® ...
Nasdaq5 天
JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF ...
flexible and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload). The Aquadex SmartFlow system is indicated for temporary (up to 8 hours) or extended ...
Nasdaq3 天
Nuwellis, Inc. Reports 60% Reduction in Heart Failure Events with Aquadex® SmartFlow ...
The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload).
Nuwellis, Inc.: JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in ...
WHOWHATWHEREWHENWHYNuwellis, Inc., and Dr. Sean P. Pinney and Dr. Maria V. DeVitaUpdated analysis of the AVOID-HF study data shows that Aquadex® SmartFlow ultrafiltration therapy led to a 60% reductio ...